The use of human adipose-derived stem cells based cytotoxicity assay for acute toxicity test

Regulatory Toxicology and Pharmacology

Volumn 73, Issue 3, 2015, Pages 992-998

  Abud, Ana Paula Ressetti ^a   Zych, Jaiesa ^a,c   Reus, Thamile Luciane ^a   Kuligovski, Crisciele ^a   de Moraes, Elizabeth ^a,b   Dallagiovanna, Bruno ^a   de Aguiar, Alessandra Melo ^a  

^a INSTITUTO CARLOS CHAGAS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c TECPAR   (Brazil)

Author keywords

Cytotoxicity; Stem cells; Toxicity prediction

Indexed keywords

ARSENITE SODIUM; CYCLOHEXIMIDE; DICHROMATE SODIUM; DODECYL SULFATE SODIUM; ETHYLENE GLYCOL; GLYCEROL; HEXACHLOROPHENE; INDOMETACIN; NEUTRAL RED; OXALIC ACID DERIVATIVE; POTASSIUM CHLORIDE; PROPRANOLOL; TRICHLOROACETIC ACID;

3T3 CELL LINE; ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY TEST; HUMAN; HUMAN CELL; IC50; LD50; MOUSE; NEUTRAL RED UPTAKE ASSAY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; TOXICITY TESTING; ADIPOSE TISSUE; ANIMAL; BIOASSAY; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; EVALUATION STUDY; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; RISK ASSESSMENT; STEM CELL;

ADIPOSE TISSUE; ANIMALS; BALB 3T3 CELLS; BIOLOGICAL ASSAY; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INHIBITORY CONCENTRATION 50; MICE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; STEM CELLS; TOXICITY TESTS, ACUTE;

EID: 84952717419     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.09.015     Document Type: Article

References (28)

1. Baer P.C. Adipose-derived mesenchymal stromal/stem cells: an update on their phenotype in vivo and in vitro. World J. Stem Cells 2014, 6:256-265. 10.4252/wjsc.v6.i3.256.
2. Behar R.Z., Bahl V., Wang Y., Lin S., Xu N., Davis B., Talbot P. A method for rapid dose-response screening of environmental chemicals using human embryonic stem cells. J. Pharmacol. Toxicol. Methods 2012, 66:238-245. 10.1016/j.vascn.2012.07.003.
3. Bellin M., Marchetto M.C., Gage F.H., Mummery C.L. Induced pluripotent stem cells: the new patient?. Nat. Rev. Mol. Cell Biol. 2012, 13:713-726. 10.1038/nrm3448.
4. Coleman R.A. Human-based systems in drug and chemical safety testing-toward replacement, the 'single R'. ATLA 2014, 42(6):357-366.
5. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317. 10.1080/14653240600855905.
6. ECVAM Embryonic Stem Cell Test 2010, 1-31. DB-ALM Protocol No. 113.
7. Eskes C., Sa-Rocha Vde M., Nunes J., Presgrave O., de Carvalho D., Masson P., Rivera E., Coecke S., Kreysa J., Hartung T. Proposal for a Brazilian centre on alternative test methods. Altex 2009, 26:303-306.
8. Flecknell P. Replacement, reduction and refinement. Altex 2002, 19:73-78.
9. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 2007, 100:1249-1260. 10.1161/01.res.0000265074.83288.09.
10. Guo L.W., Wu Q., Green B., Nolen G., Shi L., Losurdo J., Deng H., Bauer S., Fang J.L., Ning B. Cytotoxicity and inhibitory effects of low-concentration triclosan on adipogenic differentiation of human mesenchymal stem cells. Toxicol. Appl. Pharmacol. 2012, 262:117-123. 10.1016/j.taap.2012.04.024.
11. Halle W. The registry of cytotoxicity: toxicity testing in cell cultures to predict acute toxicity (LD50) and to reduce testing in animals. Altern. Lab. Anim. ATLA 2003, 31:89-198.
12. Hook L.A. Stem cell technology for drug discovery and development. Drug Discov. Today 2012, 17:336-342. 10.1016/j.drudis.2011.11.001.
13. ICCVAM Background Review Document: in Vitro Basal Cytotoxicity Test Methods for Estimating Acute Oral Systemic Toxicity 2006, vol. 1. NIH Publication No: 07-4518, National Institute for Environmental Health Sciences, Research Triangle Park, NC, Available at:. http://ntp.niehs.nih.gov/iccvam/docs/acutetox_docs/brd_tmer/brdvol1_nov2006.pdf.
14. ICCVAM Background Review Document: in Vitro Basal Cytotoxicity Test Methods for Estimating Acute Oral Systemic Toxicity 2006, vol. 2. NIH Publication No: 07-4518, Research Triangle Park, NC., National Institute for Environmental Health Sciences, Research Triangle Park, NC, Available at:. http://ntp.niehs.nih.gov/iccvam/docs/acutetox_docs/brd_tmer/brdvol2_nov2006.pdf.
15. ICCVAM Recommended Test Method Protocol: BALB/c 3T3 NRU Cytotoxicity Test Method 2006, Available at:. http://iccvam.niehs.nih.gov/methods/acutetox/inv_nru_tmer.htm.
16. ICCVAM Recommended Test Method Protocol: Normal Human Keratinocyte NRU Cytotoxicity Test Method 2006, Available at:. http://iccvam.niehs.nih.gov/methods/acutetox/inv_nru_tmer.htm.
17. ICCVAM Test Method Evaluation Report (TMER): in Vitro Cytotoxicity Test Methods for Estimating Starting Doses for Acute Oral Systemic Toxicity Testing 2006, NIH Publication No: 07-4519, National Institute for Environmental Health Sciences, Research Triangle Park, NC, Available at:. http://ntp.niehs.nih.gov/iccvam/docs/acutetox_docs/brd_tmer/at-tmer-complete.pdf.
18. Kandarova H., Letasiova S. Alternative methods in toxicology: pre-validated and validated methods. Interdiscip. Toxicol. 2011, 4:107-113. 10.2478/v10102-011-0018-6.
19. Kang K.S., Trosko J.E. Stem cells in toxicology: fundamental biology and practical considerations. Toxicol. Sci. Off. J. Soc. Toxicol. 2011, 120(Suppl. 1):S269-S289. 10.1093/toxsci/kfq370.
20. Liebsch M., Grune B., Seiler A., Butzke D., Oelgeschlager M., Pirow R., Adler S., Riebeling C., Luch A. Alternatives to animal testing: current status and future perspectives. Arch. Toxicol. 2011, 85:841-858. 10.1007/s00204-011-0718-x.
21. Luttun A., Verfaillie C.M. A perspective on stem cells as a tool for in vitro testing. Altex 2005, 22:388-392.
22. Nava M.M., Raimondi M.T., Pietrabissa R. Controlling self-renewal and differentiation of stem cells via mechanical cues. J. Biomed. Biotechnol. 2012, 2012:1-12. 10.1155/2012/797410.
23. OECD Guidance Document on Using Cytotoxicity Tests to Estimate Starting Doses for Acute Oral Systemic Toxicity Tests No. 129 2010, OECD Environment, Health and Safety Publications, Paris, Available at:. http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2010)20&doclanguage=en.
24. Presgarve O.A.F. The need for the establishment of a brazilian centre for the validation of alternative methods (BraCVAM). ATLA 2008, 36:705-708.
25. Rajamohan D., Matsa E., Kalra S., Crutchley J., Patel A., George V., Denning C. Current status of drug screening and disease modelling in human pluripotent stem cells. BioEssays News Rev. Mol. Cell. Dev. Biol. 2013, 35:281-298. 10.1002/bies.201200053.
26. Russell W.M.S., Burch R.L. The Principles of Humane Experimental Technique 1959, Methuen & Co. Ltd., London.
27. Scanu M., Mancuso L., Cao G. Evaluation of the use of human mesenchymal stem cells for acute toxicity tests. Toxicol. Vitro Int. J. Publ. Assoc. BIBRA 2011, 25:1989-1995. 10.1016/j.tiv.2011.07.006.
28. Stokes W.S. Humane endpoints for laboratory animals used in regulatory testing. ILAR J. Natl. Res. Counc. Inst. Lab. Anim. Resour. 2002, 43(Suppl. l):S31-S38.